The global cancer diagnostics market size is expected to hit around USD 258.54 billion by 2030 and progressing a CAGR of 8.4% over the forecast period 2022 to 2030.
The on cancer
diagnostics Market, which provides a business strategy, research &
development activities, concise outline of the market valuation, valuable
insights pertaining to market share, size, supply chain analysis, competitive
landscape and regional proliferation of this industry.
Download
Free Sample@ https://www.precedenceresearch.com/sample/1194
Scope of the Report
| Report Highlights | Details |
| Market Size | US$ 258.54 Billion by 2030 |
| Growth Rate | CAGR of 8.4% From 2022 to 2030 |
| Base Year | 2021 |
| Historic Data | 2017 to 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Test Type, Application |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
A recent
report provides crucial insights along with application based and forecast
information in the Global Cancer diagnostics Market. The report provides a
comprehensive analysis of key factors that are expected to drive the growth of
this market. This study also provides a detailed overview of the opportunities
along with the current trends observed in the Cancer diagnostics market.
A
quantitative analysis of the industry is compiled for a period of 10 years in
order to assist players to grow in the market. Insights on specific revenue
figures generated are also given in the report, along with projected revenue at
the end of the forecast period.
Companies
and Manufacturers Covered
The study
covers key players operating in the market along with prime schemes and
strategies implemented by each player to hold high positions in the industry.
Such a tough vendor landscape provides a competitive outlook of the industry,
consequently existing as a key insight. These insights were thoroughly analysed
and prime business strategies and products that offer high revenue generation
capacities were identified. Key players of the global Cancer diagnostics market
are included as given below:
Cancer diagnostics Market Key Players
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Becton, Dickinson and Company
- GE Healthcare
- QIAGEN N.V.
- Abbott Laboratories, Inc.
- Roche Diagnostics
- Siemens Healthcare
- Philips Healthcare
- R. Bard, Inc.
- bioMérieux SA
- NeoGenomics Laboratories, Inc.
- Volpara Solutions Limited
- Hologic Inc.
- Canon Medical Systems Corporation
- PenRad Technologies Inc.
- BioNTech Diagnostics GmbH
- BioGenex
Market Segments
- Consumables
- Antibodies
- Kits & Reagents
- Probes
- Other Consumables
- Instruments
- Pathology-based Instruments
- Slide Staining Systems
- Tissue Processing Systems
- Cell Processors
- PCR Instruments
- NGS Instruments
- Microarrays
- Other Pathology-based Instruments
- Imaging Instruments
- CT Systems
- Ultrasound Systems
- MRI Systems
- Mammography Systems
- Nuclear Imaging Systems
- Biopsy Instruments
By Technology
- IVD Testing
- Polymerase Chain Reaction (PCR)
- In Situ Hybridization (ISH)
- Immunohistochemistry (IHC)
- Next-generation Sequencing (NGS)
- Microarrays
- Flow Cytometry
- Immunoassays
- Other IVD Testing Technologies
- Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Mammography
- Ultrasound
- Biopsy Technique
By Application
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Blood Cancer
- Kidney Cancer
- Liver Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Others
By End Use
- Hospitals and Clinics
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Research Institutes
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global cancer
diagnostics market based on product, and region
- To provide detailed information regarding the major
factors influencing the growth of the market (drivers, opportunities, and
industry-specific challenges)
- To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the total
market
- To analyze opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to
four main regions—North America,
Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively
analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as
acquisitions, expansions, new product launches, and partnerships in the cancer
diagnostics market
Table of Content
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cancer Diagnostics Market
5.1. COVID-19 Landscape: Cancer Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cancer Diagnostics Market, By Product
8.1. Cancer Diagnostics Market, by Product Type, 2022-2030
8.1.1. Consumables (Antibodies, Kits & Reagents, Probes, Other Consumables)
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Instruments (Pathology-based Instruments, Slide Staining Systems, Tissue Processing Systems, Cell Processors, Others)
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Imaging Instruments (CT Systems, Ultrasound Systems, MRI Systems, Mammography Systems, Nuclear Imaging Systems)
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Biopsy Instruments
8.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Cancer Diagnostics Market, By Technology
9.1. Cancer Diagnostics Market, by Technology, 2022-2030
9.1.1. IVD Testing (PCR, ISH, IHC, NGS, Microarrays, Flow Cytometry, Immunoassays)
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Imaging (MRI, CT, PET, Mammography, Ultrasound)
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Biopsy Technique
9.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Cancer Diagnostics Market, By Application
10.1. Cancer Diagnostics Market, by Application, 2022-2030
10.1.1. Breast Cancer
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Colorectal Cancer
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Cervical Cancer
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Lung Cancer
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Prostate Cancer
10.1.5.1. Market Revenue and Forecast (2019-2030)
10.1.6. Skin Cancer
10.1.6.1. Market Revenue and Forecast (2019-2030)
10.1.7. Blood Cancer
10.1.7.1. Market Revenue and Forecast (2019-2030)
10.1.8. Kidney Cancer
10.1.8.1. Market Revenue and Forecast (2019-2030)
10.1.9. Liver Cancer
10.1.9.1. Market Revenue and Forecast (2019-2030)
10.1.10. Pancreatic Cancer
10.1.10.1. Market Revenue and Forecast (2019-2030)
10.1.11. Ovarian Cancer
10.1.11.1. Market Revenue and Forecast (2019-2030)
10.1.12. Others
10.1.12.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Cancer Diagnostics Market, By End Use
11.1. Cancer Diagnostics Market, by End Use, 2022-2030
11.1.1. Hospitals and Clinics
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Diagnostic Laboratories
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Diagnostic Imaging Centers
11.1.3.1. Market Revenue and Forecast (2019-2030)
11.1.4. Research Institutes
11.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Cancer Diagnostics Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.2. Market Revenue and Forecast, by Technology (2019-2030)
12.1.3. Market Revenue and Forecast, by Application (2019-2030)
12.1.4. Market Revenue and Forecast, by End Use (2019-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.5.2. Market Revenue and Forecast, by Technology (2019-2030)
12.1.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.1.5.4. Market Revenue and Forecast, by End Use (2019-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.1.6.2. Market Revenue and Forecast, by Technology (2019-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.1.6.4. Market Revenue and Forecast, by End Use (2019-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.2. Market Revenue and Forecast, by Technology (2019-2030)
12.2.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.4. Market Revenue and Forecast, by End Use (2019-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.5.2. Market Revenue and Forecast, by Technology (2019-2030)
12.2.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.5.4. Market Revenue and Forecast, by End Use (2019-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.6.2. Market Revenue and Forecast, by Technology (2019-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.6.4. Market Revenue and Forecast, by End Use (2019-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.7.2. Market Revenue and Forecast, by Technology (2019-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.7.4. Market Revenue and Forecast, by End Use (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.2.8.2. Market Revenue and Forecast, by Technology (2019-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2019-2030)
12.2.8.4. Market Revenue and Forecast, by End Use (2019-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.2. Market Revenue and Forecast, by Technology (2019-2030)
12.3.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.4. Market Revenue and Forecast, by End Use (2019-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.5.2. Market Revenue and Forecast, by Technology (2019-2030)
12.3.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.5.4. Market Revenue and Forecast, by End Use (2019-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.6.2. Market Revenue and Forecast, by Technology (2019-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.6.4. Market Revenue and Forecast, by End Use (2019-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.7.2. Market Revenue and Forecast, by Technology (2019-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.7.4. Market Revenue and Forecast, by End Use (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.3.8.2. Market Revenue and Forecast, by Technology (2019-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2019-2030)
12.3.8.4. Market Revenue and Forecast, by End Use (2019-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.2. Market Revenue and Forecast, by Technology (2019-2030)
12.4.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.4. Market Revenue and Forecast, by End Use (2019-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.5.2. Market Revenue and Forecast, by Technology (2019-2030)
12.4.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.5.4. Market Revenue and Forecast, by End Use (2019-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.6.2. Market Revenue and Forecast, by Technology (2019-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.6.4. Market Revenue and Forecast, by End Use (2019-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.7.2. Market Revenue and Forecast, by Technology (2019-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.7.4. Market Revenue and Forecast, by End Use (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
12.4.8.2. Market Revenue and Forecast, by Technology (2019-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2019-2030)
12.4.8.4. Market Revenue and Forecast, by End Use (2019-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.2. Market Revenue and Forecast, by Technology (2019-2030)
12.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.5.4. Market Revenue and Forecast, by End Use (2019-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.5.2. Market Revenue and Forecast, by Technology (2019-2030)
12.5.5.3. Market Revenue and Forecast, by Application (2019-2030)
12.5.5.4. Market Revenue and Forecast, by End Use (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
12.5.6.2. Market Revenue and Forecast, by Technology (2019-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2019-2030)
12.5.6.4. Market Revenue and Forecast, by End Use (2019-2030)
Chapter 13. Company Profiles
13.1. Agilent Technologies, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Illumina, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Becton, Dickinson and Company
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. GE Healthcare
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. QIAGEN N.V.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Abbott Laboratories, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Roche Diagnostics
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Siemens Healthcare
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Philips Healthcare
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. R. Bard, Inc.
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments